Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,725,861
in 7 filings, $11.7M under 10b5-1 plans

Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 9 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-06-14 Matis Louis SVP, Chief Development Officer Purchase +7,915 $1.71 $14K 10,000
2016-06-13 DEPTULA-HICKS DARLENE M SVP, Chief Financial Officer Purchase +5,000 $1.66 $8K 5,000
2016-06-13 Yoder Stephen S. President and CEO Purchase +6,000 $1.68 $10K 6,000
2016-06-13 Matis Louis SVP, Chief Development Officer Purchase +2,085 $1.68 $4K 2,085
2016-04-27 Khuong Chau Quang Director Grant or award · Stock Option (right to buy) +8,174 8,174
2016-04-27 Richman Michael Director Grant or award · Stock Option (right to buy) +7,679 7,679
2016-02-16 Prelack Steven Director Grant or award · Stock Option (right to buy) +20,000 20,000
2016-02-16 BIZZARI JEAN-PIERRE Director Grant or award · Stock Option (right to buy) +20,000 20,000
2016-02-16 Khuong Chau Quang Director Grant or award · Stock Option (right to buy) +20,000 20,000
2016-02-16 Richman Michael Director Grant or award · Stock Option (right to buy) +20,000 20,000
2016-02-12 Yoder Stephen S. President and CEO Grant or award · Stock Option (right to buy) +492,000 492,000
2016-01-15 Khuong Chau Quang Director Grant or award · Stock Option (right to buy) +10,277 10,277

Page 21 of 21 · 412 trades